psychedelics-investing NeonMind Biosciences: Using Psychedelics as Treatment for Mental Health Disorders and Weight Management
psychedelics-investing NeonMind To Improve Patient Care and Data Management by Adopting Digital Platform for Ketamine Treatments in Preparation of Opening Its Inaugural Specialty Mental Health Clinic
psychedelics-investing NeonMind Engages Leading Digital Platform for Medical Education and Adoption of Ketamine Treatments in Preparation of Opening its Inaugural Specialty Mental Health Clinic
psychedelics-investing NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows
psychedelics-investing NeonMind Unveils Initial Treatment Offering at Specialty Mental Health Clinic in Mississauga
psychedelics-investing NeonMind Announces Positive Preclinical Results Demonstrating the Efficacy of Psilocybin in Reducing Weight Gain in Obese Animal Subjects
psychedelics-investing NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss
psychedelics-investing NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments
Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center
Stellar AfricaGold Intersects Multiple Gold-Bearing Zones and Confirms Structural Controls at Tichka Est, Morocco - Drilling Resumed on January 30, 2026
